News

Published on 30 May 2024 on Bloomberg via Yahoo Finance

Summit Shares Soar After Cancer Drug Tops Merck’s Keytruda

Article preview image

(Bloomberg) -- Summit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its goal in patients with non-small cell lung cancer.

Most Read from Bloomberg

Donald Trump Becomes First Former US President Guilty of CrimesSouth Africa Election Results With 29% Voting Districts InWall Street Billionaires Are Rushing to Back Trump, Verdict Be DamnedTrump Is Guilty on All Counts in Hush-Money Case. Now What?World’s Largest Nuclear Plant Sits Idle While Energy Needs Soar

Read the rest of the article
NASDAQ.SMMT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day...

Shares of SentinelOne, Inc. S shares fell sharply during Friday's session after the company poste...

Benzinga 31 May 2024
Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus...

Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Ver...

Benzinga via Yahoo Finance 31 May 2024
Why Zscaler Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Zscaler...

Shares of Zscaler, Inc. ZS rose sharply in today's pre-market trading after the company reported ...

Benzinga 31 May 2024
Marvell Technology Posts Weak Q1 Results, Joins MongoDB, Dell Technologies And Other Big Stocks...

U.S. stock futures were mostly lower this morning, with the Nasdaq futures falling around 70 poin...

Benzinga 31 May 2024
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster

jumped more than 270% Thursday after the company said its experimental cancer drug outperformed...

Market Watch 30 May 2024
Ivonescimab shows promise in NSCLC Phase III trial By Investing.com

Summit Therapeutics Inc. (NASDAQ: NASDAQ:SMMT) announced that its Phase III clinical trial,...

Investing.com 30 May 2024
Summit Shares Soar After Cancer Drug Tops Merck’s Keytruda

(Bloomberg) -- Summit Therapeutics Inc. shares jumped after the biotech company said a late-stage...

Bloomberg via Yahoo Finance 30 May 2024
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In...

Shares of Applied DNA Sciences, Inc. APDN fell sharply during Tuesday's session after the company...

Benzinga 28 May 2024
Summit spikes as Citi launches at Buy on lead asset (NASDAQ:SMMT)

Summit Therapeutics (SMMT) stock rises as Citi initiates coverage with a Buy recommendation, citi...

Seeking Alpha 7 May 2024
Foghorn Therapeutics Q1 2024 Earnings: Misses Analyst Revenue Projections Amidst Strategic ...

Revenue: Reported Q1 revenue of $5.1 million, slightly below the prior year's $5.3 million and fa...

GuruFocus.com via Yahoo Finance 6 May 2024

Copyright Statfolio @ 2024

Social Accounts